US Stock MarketDetailed Quotes

Ascendis Pharma A/S (ASND)

Watchlist
  • 205.830
  • -9.210-4.28%
Close Jan 16 16:00 ET
  • 205.850
  • +0.020+0.01%
Post 17:36 ET
12.70BMarket Cap-46.41P/E (TTM)

Ascendis Pharma A/S (ASND) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
269.40%213.63M
339.04%158.05M
5.28%100.95M
36.34%363.64M
26.30%173.92M
20.40%57.83M
-24.04%36M
185.49%95.89M
421.20%266.72M
501.42%137.7M
Operating revenue
269.40%213.63M
339.04%158.05M
5.28%100.95M
36.34%363.64M
26.30%173.92M
20.40%57.83M
-24.04%36M
185.49%95.89M
421.20%266.72M
501.42%137.7M
Cost of revenue
99.57%22.35M
174.29%31.45M
131.43%17.52M
-0.31%44.26M
-27.93%14.02M
51.61%11.2M
-11.32%11.47M
63.80%7.57M
265.78%44.4M
280.61%19.46M
Gross profit
310.19%191.28M
416.03%126.6M
-5.53%83.44M
43.66%319.38M
35.22%159.89M
14.73%46.63M
-28.82%24.53M
204.91%88.33M
469.52%222.32M
564.90%118.25M
Operating expense
25.74%180.28M
13.79%179.55M
33.99%184.2M
-11.76%598.15M
3.01%159.51M
-18.10%143.38M
-9.99%157.79M
-20.38%137.47M
12.82%677.86M
-6.24%154.86M
Selling and administrative expenses
63.93%111.69M
46.22%105.71M
43.22%95.65M
9.95%284.55M
26.81%78.78M
8.98%68.13M
2.87%72.3M
0.37%66.78M
19.89%258.79M
21.40%62.13M
-General and administrative expense
63.93%111.69M
46.22%105.71M
46.39%95.65M
9.95%284.55M
26.81%78.78M
8.98%68.13M
4.62%72.3M
--65.34M
19.89%258.79M
--62.13M
Research and development costs
-9.06%66.88M
-13.76%71.99M
22.52%86.6M
-25.75%307M
-12.75%79.3M
-34.01%73.54M
-20.51%83.48M
-33.39%70.69M
8.91%413.45M
-16.33%90.88M
Depreciation amortization depletion
0.88%1.72M
-8.23%1.85M
34.53%1.94M
17.32%6.6M
-22.54%1.43M
54.59%1.7M
70.93%2.02M
--1.45M
4.58%5.62M
--1.85M
-Depreciation and amortization
0.88%1.72M
-8.23%1.85M
34.53%1.94M
17.32%6.6M
-22.54%1.43M
54.59%1.7M
70.93%2.02M
--1.45M
4.58%5.62M
--1.85M
Operating profit
111.37%11M
60.26%-52.95M
-105.02%-100.76M
38.81%-278.76M
101.05%383K
28.02%-96.74M
5.38%-133.26M
65.80%-49.15M
18.92%-455.54M
75.16%-36.61M
Net non-operating interest income expense
-22.34%-16.4M
-25.10%22.04M
78.35%-15.93M
-217.79%-39.9M
93.75%-3.37M
34.23%-13.4M
11.36%29.43M
-308.49%-73.59M
46.02%-12.55M
24.80%-53.9M
Non-operating interest income
25.13%3.33M
12.25%55.06M
707.10%28.85M
-14.81%14.36M
109.04%5.44M
-35.83%2.66M
37.17%49.05M
-92.08%3.58M
127.00%16.86M
9.41%-60.13M
Non-operating interest expense
22.80%19.72M
68.25%33.02M
-41.96%44.79M
48.65%65.5M
138.01%20.05M
-34.50%16.06M
110.24%19.62M
684.16%77.16M
43.62%44.07M
58.93%8.43M
Total other finance cost
----
----
----
23.24%-11.25M
----
----
----
----
---14.65M
----
Other net income (expense)
-534.31%-51.97M
23.02%-4.1M
498.98%23.13M
-802.35%-54.58M
-465.11%-34.4M
276.14%11.97M
28.57%-5.32M
-372.37%-5.8M
-183.40%-6.05M
-44.54%9.42M
Gain on sale of security
-372.27%-44.47M
----
----
-379.63%-34.52M
---29.83M
--16.33M
----
----
-50.52%12.35M
----
Earnings from equity interest
-71.77%-7.5M
23.02%-4.1M
558.57%26.58M
-9.05%-20.06M
-56.46%-4.58M
35.72%-4.37M
28.57%-5.32M
-372.37%-5.8M
-3.94%-18.4M
63.27%-2.92M
Special income (charges)
--0
--0
---3.45M
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
--0
--0
--3.45M
----
----
--0
--0
--0
----
----
Income before tax
41.56%-57.37M
67.93%-35.01M
27.20%-93.57M
21.28%-373.24M
53.90%-37.38M
39.24%-98.18M
10.43%-109.15M
-17.25%-128.53M
17.94%-474.14M
59.87%-81.09M
Income tax
254.61%3.62M
1,580.35%3.85M
-57.70%1.06M
-33.68%4.84M
-81.26%1.09M
58.14%1.02M
153.38%229K
93.37%2.51M
35.82%7.3M
8.24%5.79M
Net income
38.52%-60.99M
64.48%-38.86M
27.79%-94.63M
21.47%-378.08M
55.72%-38.47M
38.85%-99.2M
9.93%-109.38M
-18.14%-131.04M
17.45%-481.45M
58.11%-86.88M
Net income continuous Operations
38.52%-60.99M
64.48%-38.86M
27.79%-94.63M
21.47%-378.08M
55.72%-38.47M
38.85%-99.2M
9.93%-109.38M
-18.14%-131.04M
17.45%-481.45M
58.11%-86.88M
Minority interest income
Net income attributable to the parent company
38.52%-60.99M
64.48%-38.86M
27.79%-94.63M
21.47%-378.08M
55.72%-38.47M
38.85%-99.2M
9.93%-109.38M
-18.14%-131.04M
17.45%-481.45M
58.11%-86.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
38.52%-60.99M
64.48%-38.86M
27.79%-94.63M
21.47%-378.08M
55.72%-38.47M
38.85%-99.2M
9.93%-109.38M
-18.14%-131.04M
17.45%-481.45M
58.11%-86.88M
Basic earnings per share
41.86%-1
66.49%-0.64
31.30%-1.58
23.63%-6.53
58.44%-0.64
40.28%-1.72
11.57%-1.91
-16.16%-2.3
17.79%-8.55
58.38%-1.54
Diluted earnings per share
41.86%-1
62.90%-0.82
31.30%-1.58
23.63%-6.53
58.44%-0.64
40.28%-1.72
-2.31%-2.21
-16.16%-2.3
17.79%-8.55
58.38%-1.54
Dividend per share
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 269.40%213.63M339.04%158.05M5.28%100.95M36.34%363.64M26.30%173.92M20.40%57.83M-24.04%36M185.49%95.89M421.20%266.72M501.42%137.7M
Operating revenue 269.40%213.63M339.04%158.05M5.28%100.95M36.34%363.64M26.30%173.92M20.40%57.83M-24.04%36M185.49%95.89M421.20%266.72M501.42%137.7M
Cost of revenue 99.57%22.35M174.29%31.45M131.43%17.52M-0.31%44.26M-27.93%14.02M51.61%11.2M-11.32%11.47M63.80%7.57M265.78%44.4M280.61%19.46M
Gross profit 310.19%191.28M416.03%126.6M-5.53%83.44M43.66%319.38M35.22%159.89M14.73%46.63M-28.82%24.53M204.91%88.33M469.52%222.32M564.90%118.25M
Operating expense 25.74%180.28M13.79%179.55M33.99%184.2M-11.76%598.15M3.01%159.51M-18.10%143.38M-9.99%157.79M-20.38%137.47M12.82%677.86M-6.24%154.86M
Selling and administrative expenses 63.93%111.69M46.22%105.71M43.22%95.65M9.95%284.55M26.81%78.78M8.98%68.13M2.87%72.3M0.37%66.78M19.89%258.79M21.40%62.13M
-General and administrative expense 63.93%111.69M46.22%105.71M46.39%95.65M9.95%284.55M26.81%78.78M8.98%68.13M4.62%72.3M--65.34M19.89%258.79M--62.13M
Research and development costs -9.06%66.88M-13.76%71.99M22.52%86.6M-25.75%307M-12.75%79.3M-34.01%73.54M-20.51%83.48M-33.39%70.69M8.91%413.45M-16.33%90.88M
Depreciation amortization depletion 0.88%1.72M-8.23%1.85M34.53%1.94M17.32%6.6M-22.54%1.43M54.59%1.7M70.93%2.02M--1.45M4.58%5.62M--1.85M
-Depreciation and amortization 0.88%1.72M-8.23%1.85M34.53%1.94M17.32%6.6M-22.54%1.43M54.59%1.7M70.93%2.02M--1.45M4.58%5.62M--1.85M
Operating profit 111.37%11M60.26%-52.95M-105.02%-100.76M38.81%-278.76M101.05%383K28.02%-96.74M5.38%-133.26M65.80%-49.15M18.92%-455.54M75.16%-36.61M
Net non-operating interest income expense -22.34%-16.4M-25.10%22.04M78.35%-15.93M-217.79%-39.9M93.75%-3.37M34.23%-13.4M11.36%29.43M-308.49%-73.59M46.02%-12.55M24.80%-53.9M
Non-operating interest income 25.13%3.33M12.25%55.06M707.10%28.85M-14.81%14.36M109.04%5.44M-35.83%2.66M37.17%49.05M-92.08%3.58M127.00%16.86M9.41%-60.13M
Non-operating interest expense 22.80%19.72M68.25%33.02M-41.96%44.79M48.65%65.5M138.01%20.05M-34.50%16.06M110.24%19.62M684.16%77.16M43.62%44.07M58.93%8.43M
Total other finance cost ------------23.24%-11.25M-------------------14.65M----
Other net income (expense) -534.31%-51.97M23.02%-4.1M498.98%23.13M-802.35%-54.58M-465.11%-34.4M276.14%11.97M28.57%-5.32M-372.37%-5.8M-183.40%-6.05M-44.54%9.42M
Gain on sale of security -372.27%-44.47M---------379.63%-34.52M---29.83M--16.33M---------50.52%12.35M----
Earnings from equity interest -71.77%-7.5M23.02%-4.1M558.57%26.58M-9.05%-20.06M-56.46%-4.58M35.72%-4.37M28.57%-5.32M-372.37%-5.8M-3.94%-18.4M63.27%-2.92M
Special income (charges) --0--0---3.45M----------0--0--0--------
-Less:Impairment of capital assets --0--0--3.45M----------0--0--0--------
Income before tax 41.56%-57.37M67.93%-35.01M27.20%-93.57M21.28%-373.24M53.90%-37.38M39.24%-98.18M10.43%-109.15M-17.25%-128.53M17.94%-474.14M59.87%-81.09M
Income tax 254.61%3.62M1,580.35%3.85M-57.70%1.06M-33.68%4.84M-81.26%1.09M58.14%1.02M153.38%229K93.37%2.51M35.82%7.3M8.24%5.79M
Net income 38.52%-60.99M64.48%-38.86M27.79%-94.63M21.47%-378.08M55.72%-38.47M38.85%-99.2M9.93%-109.38M-18.14%-131.04M17.45%-481.45M58.11%-86.88M
Net income continuous Operations 38.52%-60.99M64.48%-38.86M27.79%-94.63M21.47%-378.08M55.72%-38.47M38.85%-99.2M9.93%-109.38M-18.14%-131.04M17.45%-481.45M58.11%-86.88M
Minority interest income
Net income attributable to the parent company 38.52%-60.99M64.48%-38.86M27.79%-94.63M21.47%-378.08M55.72%-38.47M38.85%-99.2M9.93%-109.38M-18.14%-131.04M17.45%-481.45M58.11%-86.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 38.52%-60.99M64.48%-38.86M27.79%-94.63M21.47%-378.08M55.72%-38.47M38.85%-99.2M9.93%-109.38M-18.14%-131.04M17.45%-481.45M58.11%-86.88M
Basic earnings per share 41.86%-166.49%-0.6431.30%-1.5823.63%-6.5358.44%-0.6440.28%-1.7211.57%-1.91-16.16%-2.317.79%-8.5558.38%-1.54
Diluted earnings per share 41.86%-162.90%-0.8231.30%-1.5823.63%-6.5358.44%-0.6440.28%-1.72-2.31%-2.21-16.16%-2.317.79%-8.5558.38%-1.54
Dividend per share
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More